Affirmative Action And Women In Science: Post Hoc, Ergo Propter Hoc?

"The Committee on Affirmative Action and the Status of Women of the Society for [insert organization name here] (a) declares that its primary objective is to render itself obsolete and (b) requests that it be made a permanent, standing committee of the Society, rather than a temporary, ad hoc committee." While such a statement could be issued within any organization, it actually happened twice in the last year within societies to which I belong-one interdisciplinary and one subject-oriented. W

Written byVirginia Trimble
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"The Committee on Affirmative Action and the Status of Women of the Society for [insert organization name here] (a) declares that its primary objective is to render itself obsolete and (b) requests that it be made a permanent, standing committee of the Society, rather than a temporary, ad hoc committee." While such a statement could be issued within any organization, it actually happened twice in the last year within societies to which I belong-one interdisciplinary and one subject-oriented. What in the world is going on when something that was supposed to be temporary wants to become permanent? What, if anything, should we do about it? And who am I to be telling you?

To take the last question first, I am an old-or anyhow aging-tenured, female academic, married to a (the same) fellow scientist for 20-some years, and the holder of a 1968 Ph.D. in astronomy from a reasonably prestigious ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies